Cargando…

Prospective randomized trial of 100u vs 200u botox in the treatment of idiopathic overactive bladder

AIM: To evaluate the clinical outcomes of two different doses of BTX-A in patients with refractory idiopathic overactive bladder. PATIENTS AND METHODS: Thirty nine patients with refractory idiopathic overactive bladder from 1/1/2008 till 30/3/2009 were evaluated in a tertiary care hospital. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlTaweel, Waleed, Mokhtar, Alaa, Rabah, Danny M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130480/ https://www.ncbi.nlm.nih.gov/pubmed/21747594 http://dx.doi.org/10.4103/0974-7796.82170

Ejemplares similares

Cost-Utility Analysis of Oxybutynin vs. OnabotulinumtoxinA (Botox) in the Treatment of Overactive Bladder Syndrome
por: Shabir, Habiba, et al.
Publicado: (2021)

Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
por: Rohrsted, Malene, et al.
Publicado: (2012)

Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Nitti, Victor, et al.
Publicado: (2023)

Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
por: Abdelwahab, Osama, et al.
Publicado: (2015)

RE: Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
por: Abdelwahab, Osama, et al.
Publicado: (2016)

Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects
por: Linnebjerg, Helle, et al.
Publicado: (2020)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
por: de la Peña, Amparo, et al.
Publicado: (2015)

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
por: Kuo, Yuh-Chen, et al.
Publicado: (2016)

Transperineal versus transrectal multi-parametric magnetic resonance imaging fusion targeted prostate biopsy
por: Rabah, Danny, et al.
Publicado: (2021)

Mesons production in $p$ + U, O + U and S + U interactions at 200 Gev/nucleon
por: Abreu, M C, et al.
Publicado: (1991)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Associations between exposure to organophosphate esters and overactive bladder in U.S. adults: a cross-sectional study
por: Lin, Weilong, et al.
Publicado: (2023)

Prostate-specific Antigen Density as a Proxy for Predicting Prostate Cancer Severity: Is There Any Difference between Systematic and Targeted Biopsy?
por: Arafa, Mostafa A., et al.
Publicado: (2023)

$\omega$, $\varrho$ and $\phi$ production in $p$ + U, O + U and S + U collisions at 200 Gev/c
por: Abreu, M C, et al.
Publicado: (1990)

Short-term Effects of a Systematized Bladder Training Program for Idiopathic Overactive Bladder: A Prospective Study
por: Lee, Hahn-Ey, et al.
Publicado: (2013)

The production of $\phi$ in 200 GeV/nucleon S - U and O - U interactions
por: Baldisseri, Alberto
Publicado: (1990)

Transverse momentum of dimuons produced in $p$ - U, O - U and S - U collisions at 200 GeV/nucleon
por: Guichard, A, et al.
Publicado: (1991)

The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
por: Gubbiotti, Marilena, et al.
Publicado: (2019)

Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder
por: Zhong, Hui, et al.
Publicado: (2022)

$\pi$ and $K$ production in 200 GeV/nucleon: O - U and S - U interactions
por: Abreu, M C, et al.
Publicado: (1988)

Study of $J/\psi$ production in $p$ - U, O - U and S - U interactions at 200-GeV per nucleon
por: Baglin, C, et al.
Publicado: (1991)

$\phi$, $\varrho$, and $\omega$ production in $p$ - U, O - U and S - U reactions at 200 GeV per nucleon
por: Baglin, C, et al.
Publicado: (1991)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

TRIUMF: Topping 100 uA
Publicado: (1977)

Urodynamic characteristics of lower urinary tract of patients with idiopathic overactive bladder
por: Dekhtiar, Yuriy M., et al.
Publicado: (2019)

Transcutaneous medial plantar nerve stimulation in women with idiopathic overactive bladder
por: Yildiz, Necmettin, et al.
Publicado: (2023)

$J/\psi$ and $\rho-\omega$ production in $p$ + U, O + U and S + U collisions at 200 GeV per nucleon
por: Jouan, D, et al.
Publicado: (1991)

Efficacy of intravaginal electrical stimulation added to bladder training in women with idiopathic overactive bladder: A prospective randomized controlled trial
por: Yildiz, Necmettin, et al.
Publicado: (2021)

The production of $\varrho, \omega, \phi$ in 200 GeV/n S - U and O - U interactions
por: Guillaud, J P
Publicado: (1991)

$\psi$' and $J/\psi$ production in $p$ - U and S - U collisions at 200 GeV/nucleon
por: Ronceux, B, et al.
Publicado: (1994)

$\psi$' and $J/\psi$ production in $p$ - U and S - U collisions at 200 GeV/nucleon
por: Ronceux, B, et al.
Publicado: (1995)

Evaluation of the effect of 100U of Onabotulinum toxin A on detrusor contractility in women with idiopathic OAB: A multicentre prospective study
por: De Rienzo, Gaetano, et al.
Publicado: (2021)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
por: Sharaf, Ala’a, et al.
Publicado: (2017)

How to block botox
por: Dove, Alan W.
Publicado: (2003)

Role of botox in BPBP
por: Bhardwaj, Praveen
Publicado: (2015)

$J/\psi$ suppression in 200 GeV/nucleon: O - U, O - Cu and S - U interactions
por: Abreu, M C, et al.
Publicado: (1988)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective
por: Hamid, Rizwan, et al.
Publicado: (2014)

In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
por: Banakhar, Mai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ab0ofdo5ish9blih5a69u7pns1